Raytest

Elysia-Raytest is a long-established, revenue-generating provider of specialized hardware and software for the radiopharmaceutical and nuclear medicine sectors. The company's core focus is on ensuring the quality, safety, and regulatory compliance of radioactive drugs, primarily used in cancer diagnostics and therapy. Its growth is evidenced by a recent headquarters move, expansion of its distribution network, and a steady stream of product updates like the GINA X software and AURAS automation module. Elysia-Raytest operates as a critical infrastructure partner within the global nuclear medicine ecosystem.

Integrated hardware and software platform for radiopharmaceutical quality control, including GINA X chromatography software, AURAS automated sample handling, MUCHA Nova gamma spectroscopy, and shielded QC workstations.

Elysia-Raytest competes in a niche segment with other specialized providers of radiopharmacy QC equipment and software, such as Comecer, Trasis, and Scanflex. It differentiates through its integrated software platform (GINA) and focus on automation (AURAS). Larger analytical instrument companies may have tangential offerings but lack the same depth of specialization in radioactive sample handling.